Market Research Logo

Croatia Pharmaceuticals & Healthcare Q4 2018

Croatia Pharmaceuticals & Healthcare Q4 2018

Key View:

Innovative pharmaceutical firms will find the Croatian market challenging in the coming years. Despite Croatia being arelatively attractive destination for investment, high labour costs compared to some regional peers and a limited availability of skilledworkers - due to a small population size and a lack of science and engineering graduates - will deter foreign multinationalinvestments. Furthermore, sales of high-value medicines will continue to be restricted by healthcare funding issues and aggressivegovernment cost-containment policies targeting the pharmaceutical sector. Multinational activity in Croatia will thus remain limitedto clinical trials and marketing activities through representative offices.


Key View
SWOT
Pharmaceuticals & Healthcare SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Forecast Market
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Croatia Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Jadran Galenski Laboratorij
PLIVA (Teva Pharmaceuticals)
Belupo
Croatia Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report